Zobrazeno 1 - 10
of 7 480
pro vyhledávání: ''
Autor:
Ulrich Gatzemeier, Michael Boyer, Paolo Paoletti, Salih Emri, Christian Manegold, Claude Denham, Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski, Clet Niyikiza, E. Kaukel, Pierre Ruffié
Publikováno v:
Journal of Clinical Oncology. 41:2125-2133
PURPOSE Patients with malignant pleural mesothelioma, a rapidly progressing malignancy with a median survival time of 6 to 9 months, have previously responded poorly to chemotherapy. We conducted a phase III trial to determine whether treatment with
Autor:
Samuli Tuominen, Kristiina Uusi-Rauva, Tea Blom, Sirkku Jyrkkiö, Kaisa Tuppurainen, Erika Alanne
Publikováno v:
Future Oncology. 18:1103-1114
Background: Real-world data on diffuse large B-cell lymphoma (DLBCL) has remained incomplete. In Finland, health record data originally recorded in different hospital data record systems are collectively available via data lake technology, enabling e
Autor:
Sweety Gupta, Sumit Singh, Atokali Chophy, Sharanya Nair, Rachit Ahuja, K. Kusum, Deepa Joseph, Rajnish Arora, Amit Gupta, Manoj Gupta
Publikováno v:
Journal of the Egyptian National Cancer Institute. 34
Introduction Brain metastases (BM) are associated with dismal prognosis as they cause significant morbidity and affect the quality of life of patients. Management of BM depends on the following factors: age, patient performance, size and the number o
Autor:
KAZUKI HASHIMOTO, RYUJI YASUMATSU, RYOSUKE KUGA, TAKAHIRO HONGO, HIDETAKA YAMAMOTO, MIOKO MATSUO, TAKAHIRO WAKASAKI, RINA JIROMARU, TOMOMI MANAKO, SATOSHI TOH, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, YUICHIRO KURATOMI, HIDEOKI URYU, TORAHIKO NAKASHIMA, AKIHIRO TAMAE, RISA TANAKA, MASAHIKO TAURA, TORANOSHIN TAKEUCHI, TAKAMASA YOSHIDA, TAKASHI NAKAGAWA
Publikováno v:
Anticancer Research. 42:981-989
The efficacy of programmed cell death 1 (PD-1) inhibitor therapy for patients with recurrent and/or metastatic salivary gland carcinoma (R/M SGC) remains unclear.We retrospectively analyzed 36 patients with R/M SGC treated with PD-1 inhibitor. The ex
Autor:
Athanasios, Alexopoulos, Charisios, Karanikiotis, Alexandros, Ardavanis, Ioannis, Boukovinas, Parisios, Makrantonakis, Christos, Papadimitriou, Athanasios, Athanasiadis, Anastasios, Boutis, Stylianos, Giassas, Stylianos, Kakolyris, Georgios, Koumakis, Konstantinos, Papazisis, Adamantia, Psyrri, Nikolaos, Ziras, Sofia, Baka, Nikolaos, Kentepozidis, Vasiliki, Michalaki
Publikováno v:
Anticancer Research. 42:1031-1041
This study aimed to provide real-world safety and effectiveness data of everolimus (EVE) plus exemestane (EXE) in estrogen receptor positive/human epidermal growth factor receptor 2 negative (ERThis prospective observational study was conducted by 19
Autor:
Takafumi, Shimada, Kouji, Izumi, Hiroshi, Kano, Suguru, Kadomoto, Tomoyuki, Makino, Renato, Naito, Hiroaki, Iwamoto, Hiroshi, Yaegashi, Yoshifumi, Kadono, Atsushi, Mizokami
Publikováno v:
Anticancer Research. 42:1065-1071
Ra-223 is a therapeutic agent for bone metastatic castration-resistant prostate cancer (mCRPC). We examined the efficacy of a treatment method using Ra-223 together with ethinylestradiol (EE).Patients who received Ra-223 three or more times were incl
Autor:
Yan Yuan, Zhifan Zeng, Rong-Zhen Li, Weiwei Xiao, Hui Chang, Qiaoxuan Wang, Yuanhong Gao, Wei-Hao Xie
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 117-127 (2022)
Cancer Medicine
Cancer Medicine
Background Anal squamous cell carcinoma (ASCC) is a rare malignant tumor with increasing incidence. The goal of our study was to analyze the treatment outcome and prognostic factors of ASCC in South China in the past half‐century. Methods This stud
Autor:
PAOLO AURELLO, ANDREA MINERVINI, MARCO PACE, FRANCESCO D’ANGELO, GIUSEPPE NIGRI, LAURA ANTOLINO, STEFANO VALABREGA, GIOVANNI RAMACCIATO, NICCOLÒ PETRUCCIANI
Publikováno v:
Anticancer Research. 42:25-33
Few data are available regarding metachronous liver metastases from gastric cancer. We aimed to identify data regarding the survival of these patients, considering the chosen treatment, with particular attention to the role of surgery.A systematic re
Autor:
Carolina Wälbhy, Hyuk-Joon Lee, Seong-Ho Kong, Diana Martins, Fátima Carneiro, Carolina Lemos, Ana André, Gabriela M. Almeida, Carla Pereira, Irene Gullo, Raquel Almeida, D. Almeida, Dina Leitão, Leslie Solorzano, Woo Ho Kim, Ji-Hyeon Park, Gilza Gonçalves, Sofia Campelos, Han-Kwang Yang, Carla Oliveira, C. Borges
Publikováno v:
International Journal of Cancer. 150:868-880
Surgical resection with lymphadenectomy and perioperative chemotherapy is the universal mainstay for curative treatment of gastric cancer (GC) patients with locoregional disease. However, GC survival remains asymmetric in West- and East-world regions
Publikováno v:
Cancer Biomarkers. 32:559-567
BACKGROUND: CA125 level normalization at different chemotherapy cycles has been reported to be a prognosticator in advanced epithelial ovarian cancer. OBJECTIVE: In the present study, we investigated whether the time (in days) to CA125 normalization